The role of botulinum toxin in multimodal treatment of spasticity in ambulatory children with spastic cerebral palsy: Extensive evaluation of a cost-effectiveness trial
DOI:
https://doi.org/10.2340/16501977-2680Keywords:
cerebral palsy, methodology, evaluation, botulinum toxin, spasticity, physiotherapy, casting, orthosis.Abstract
A cost-effectiveness trial (the Space Bop study) on the added value of botulinum toxin injections (BoNT-A) in the leg muscles, as part of a multimodal intervention for ambulatory children with spastic cerebral palsy in the context of a single distinct cycle of care was performed recently by our group. For a broad set of effect outcomes, we found that BoNT-A had no added value if children received comprehensive rehabilitationHowever, this counterintuitive finding was met with scepticism. Since several noteworthy facts and experiences were recorded during the course of the trial and the dissemination phase, the aim of this paper was to describe and discuss some crucial aspects of, and barriers to, the Space Bop study, related to context and perspective, design and results, as well as publication and implementation. This paper discusses 5 issues: () the design, interpretation and presentation of previous research; () the role of one?s own clinical experience and interpretation; () the aims of (BoNT-A) treatment; () conflict of interest, role of industry, and the role of history; () optimal treatment modalities and dose?response relationships. Despite the unambiguous findings from the Space Bop study, several factors hindered acceptance of the results. Awareness of these factors is important when performing rehabilitation research and disseminating and implementing research findings.Downloads
Downloads
Published
How to Cite
Issue
Section
License
All digitalized JRM contents is available freely online. The Foundation for Rehabilitation Medicine owns the copyright for all material published until volume 40 (2008), as from volume 41 (2009) authors retain copyright to their work and as from volume 49 (2017) the journal has been published Open Access, under CC-BY-NC licences (unless otherwise specified). The CC-BY-NC licenses allow third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
From 2024, articles are published under the CC-BY licence. This license permits sharing, adapting, and using the material for any purpose, including commercial use, with the condition of providing full attribution to the original publication.